Loading…
H.R. 8370119th CongressIn committeeLatest action Apr 20, 2026Decoded by AI · checked against the record
Official title: Dietary Supplement Listing Act of 2026
Introduced:
Read the official bill on Congress.govThe plain-language version leads. The official text is always the reference.
HR 8370 would require supplement makers to register each product with the FDA before it can be legally sold in the U.S.
50-second read · 4 questions answered below
This bill would require companies that make, package, or distribute dietary supplements to register each product with the FDA. Registration means submitting the product name, ingredients, serving sizes, directions, allergen warnings, and a copy of the label. The FDA would build a public online database so consumers can search this information, though some details like proprietary blend amounts and staff contact info would stay private.
This bill directly affects dietary supplement manufacturers, distributors, and retailers. Everyday consumers who buy supplements would also be affected, as they would gain access to a searchable public database of product information.
Supplements already on the market when the law takes effect would have 18 months to complete their listings, while new products would need to be listed before going on sale. Any supplement sold without a proper listing on file would be considered mislabeled under federal law, which could expose companies to legal consequences.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a House committee is reviewing it. If the Senate changes it, it goes back to the House before reaching the President.
Latest action: — Referred to the House Committee on Energy and Commerce.